Sleep duration and subclinical atherosclerosis: The Aragon Workers'' Health Study

Blasco-Colmenares, E. ; Moreno-Franco, B. (Universidad de Zaragoza) ; León Latre, M. (Universidad de Zaragoza) ; Mur-Vispe, E. ; Pocovi, M. (Universidad de Zaragoza) ; Jarauta, E. (Universidad de Zaragoza) ; Civeira, F. (Universidad de Zaragoza) ; Laclaustra, M. ; Casasnovas, J.A. (Universidad de Zaragoza) ; Guallar, E.
Sleep duration and subclinical atherosclerosis: The Aragon Workers'' Health Study
Resumen: Background and aims: Few studies have evaluated the association of sleep duration with subclinical atherosclerosis, and with heterogeneous findings. We evaluated the association of sleep duration with the presence of coronary, carotid, and femoral subclinical atherosclerosis in healthy middle-age men with low prevalence of clinical comorbidities.
Methods: We performed a cross-sectional analysis of 1968 men, 40–60 years of age, participating in the Aragon Workers' Health Study (AWHS). Duration of sleep during a typical work week was assessed by questionnaire. Coronary artery calcium scores (CACS) was assessed by computed tomography and the presence of carotid plaque and femoral plaque by ultrasound.
Results: In fully adjusted models, the odds ratios (95% CI) for CACS >0 comparing sleep durations of =5, 6, and =8 h with 7 h were 1.34 (0.98–1.85), 1.35 (1.08–1.69) and 1.21 (0.90–1.62), respectively (p = 0.04). A similar U-shaped association was observed for CACS =100 and for CACS. The corresponding odds ratios for the presence of at least one carotid plaque were =5, 6, and =8 h with 7 h were 1.23 (0.88–1.72), 1.09 (0.86–1.38), and 0.86 (0.63–1.17), respectively (p = 0.31), and for the presence of at least one femoral plaque were 1.25 (0.87–1.80), 1.19 (0.93–1.51) and 1.17 (0.86–1.61), respectively (p = 0.39).
Conclusions: Middle-aged men reporting 7 h of sleep duration had the lowest prevalence of subclinical coronary atherosclerosis as assessed by CACs. Our results support that men with very short or very long sleep durations are at increased risk of atherosclerosis.

Idioma: Inglés
DOI: 10.1016/j.atherosclerosis.2018.05.003
Año: 2018
Publicado en: Atherosclerosis 274 (2018), 35-40
ISSN: 0021-9150

Factor impacto JCR: 4.255 (2018)
Categ. JCR: PERIPHERAL VASCULAR DISEASE rank: 12 / 65 = 0.185 (2018) - Q1 - T1
Categ. JCR: CARDIAC & CARDIOVASCULAR SYSTEMS rank: 37 / 136 = 0.272 (2018) - Q2 - T1

Factor impacto SCIMAGO:

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/IIS16-0114
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI13-02686
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI14-00009
Tipo y forma: Artículo (PostPrint)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Área (Departamento): Área Medic.Prevent.Salud Públ. (Dpto. Microb.Med.Pr.,Sal.Públ.)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)


Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.


Exportado de SIDERAL (2019-07-09-12:26:18)

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2019-05-15, última modificación el 2019-07-09


Postprint:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)